Literature DB >> 21054522

Proteomic analysis of functional dyspepsia in stressed rats treated with traditional Chinese medicine "Wei Kangning".

Wei Wei1, Xia Li, Jianjun Hao, Rong Zhang, Jianli Guo, Yiqiang Zong, Yanjun Lu, Shen Qu, Jun Tian.   

Abstract

BACKGROUND AND AIM: Chinese traditional medical science is generally used as a therapeutic method against functional dyspepsia (FD) in China. Although great effort is made to understand the pharmaceutical mechanisms of Chinese traditional medicine, such as typical traditional Chinese medicine, Wei Kangning, there are still many mysteries to be uncovered.
METHODS: The model of FD was established by stimulating rats via tail damping and the rats were treated with traditional Chinese medicine, Wei Kangning. The proteins of the rat gastrointestinal tissues were extracted and run by 2-DE, then the differential proteins were identified using matrix-assisted laser desorption ionisation time-of-flight mass spectrometry and validated with Western blotting or fluorescent quantitation polymerase chain reaction.
RESULTS: A total of 228 unique proteins in FD model rats were detected with significant changes in their expression levels corresponding with traditional Chinese medicine, Wei Kangning, administration. Twenty-eight of these proteins were identified, which are involved in many biological functions, such as organism antioxidant enzymes, energy metabolism, glutathione S-transferase, pi2, superoxide dismutase 2 and alpha-enolase and so on.
CONCLUSIONS: These proteomic results presented therefore provide additional support to the hypothesis that glutathione S-transferase, pi2, superoxide dismutase 2, α-enolase and voltage-dependent anion channel are the targets of FD treated with traditional Chinese medicine, Wei Kangning.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21054522     DOI: 10.1111/j.1440-1746.2010.06566.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Upregulation of gastric norepinephrine with beta-adrenoceptors and gastric dysmotility in a rat model of functional dyspepsia.

Authors:  J Song; T Wang; X Zhang; B Li; C Zhu; S Zhang
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

2.  Weikangning therapy in functional dyspepsia and the protective role of Nrf2.

Authors:  Yujuan Chang; Wei Wei; Li Tong; Yanjun Liu; Aimin Zhou; Jiande Chen; Ruhan Wei; Ping Zhang; Xiaolan Su
Journal:  Exp Ther Med       Date:  2017-08-07       Impact factor: 2.447

Review 3.  Choosing an Animal Model for the Study of Functional Dyspepsia.

Authors:  Yang Ye; Xue-Rui Wang; Yang Zheng; Jing-Wen Yang; Na-Na Yang; Guang-Xia Shi; Cun-Zhi Liu
Journal:  Can J Gastroenterol Hepatol       Date:  2018-02-12

4.  1H NMR-Based Metabonomic Study of Functional Dyspepsia in Stressed Rats Treated with Chinese Medicine Weikangning.

Authors:  Yu Guo; Zhongfeng Li; Xinfeng Liu; Xiaolan Su; Yijie Li; Jiajie Zhu; Yilin Song; Ping Zhang; Jiande D Z Chen; Ruhan Wei; Jianqin Yang; Wei Wei
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-28       Impact factor: 2.629

5.  Simultaneous application of transcranial magnetic stimulation and low-frequency electrostatic field as treatment of carbohydrate and lipid disorders in patients with metabolic syndrome.

Authors:  Andrey A Benkov; Sergey N Nagornev; Valery K Frolkov; Valentine F Reps; Dmitriy A Edelev; Anatoly D Fesyun; Maxim Yu Yakovlev; Natalia Fedorovna Tumanova; Natalia P Sanina; Maria Chiara Maccarone
Journal:  Eur J Transl Myol       Date:  2022-02-22

Review 6.  Recent Advance in Applications of Proteomics Technologies on Traditional Chinese Medicine Research.

Authors:  Qing Ji; Fangshi Zhu; Xuan Liu; Qi Li; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

7.  Sini-san improves duodenal tight junction integrity in a rat model of functional dyspepsia.

Authors:  Xiongfei Chang; Luqing Zhao; Jiajia Wang; Xiaofang Lu; Shengsheng Zhang
Journal:  BMC Complement Altern Med       Date:  2017-08-30       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.